Patents by Inventor Tony Le Gall

Tony Le Gall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10676492
    Abstract: Disclosed are novel branched amphiphilic lipids, in particular novel branched amphiphilic lipids of general formula (II). Also disclosed is a method of synthesis for the compounds of formula (II), from unsaturated amphiphilic compounds of general formula (I). Further disclosed is the use of the compounds of general formula (II) and of the lipoplexes obtained by formulation of the compounds of general formula (II) for applications, particularly transfection, in which improved fusion properties are desired.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: June 9, 2020
    Assignees: UNIVERSITÉ DE BRETAGNE OCCIDENTALE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), CENTRE HOSPITALIER RÉGIONAL ET UNIVERSITAIRE DE BREST
    Inventors: Paul-Alain Jaffrès, Hélène Couthon-Courvès, Damien Afonso, Tristan Montier, Tony Le Gall
  • Publication number: 20180265528
    Abstract: Disclosed are novel branched amphiphilic lipids, in particular novel branched amphiphilic lipids of general formula (II). Also disclosed is a method of synthesis for the compounds of formula (II), from unsaturated amphiphilic compounds of general formula (I). Further disclosed is the use of the compounds of general formula (II) and of the lipoplexes obtained by formulation of the compounds of general formula (II) for applications, particularly transfection, in which improved fusion properties are desired.
    Type: Application
    Filed: September 23, 2016
    Publication date: September 20, 2018
    Inventors: Paul-Alain JAFFRÈS, Hélène COUTHON-COURVÈS, Damien AFONSO, Tristan MONTIER, Tony LE GALL
  • Patent number: 8178340
    Abstract: The present invention relates to human specific Escherichia coli strains.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: May 15, 2012
    Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Olivier Clermont, Erick Denamur, Tony Le Gall, Olivier Tenaillon
  • Publication number: 20110008449
    Abstract: The present invention relates to human specific Escherichia coli strains.
    Type: Application
    Filed: August 13, 2008
    Publication date: January 13, 2011
    Inventors: Olivier Clermont, Erick Denamur, Tony Le Gall, Olivier Tenaillon